Details of the Drug

General Information of Drug (ID: DMYO1IO)

Drug Name

Pabinafusp alfa

Indication

Disease Entry	ICD 11	Status	REF
Mucopolysaccharidosis II	5C56.31	Phase 2/3	[1]
------------------------------------------------------------------------------------

Drug Type

Fusion protein

Cross-matching ID

References

1	A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II. Mol Ther. 2021 Feb 3;29(2):671-679.